FDA Inspection 1255317 — Janssen Biotech Inc.
The FDA completed an inspection of Janssen Biotech Inc. on January 17, 2025 in Horsham, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 17, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Horsham, PA (United States)
Additional Details
Sponsor, Contract Research Organization